Sexually Transmitted Infections (STIs) Cervicitis Panel
Also known as: Trichomoniasis, Vaginitis, CT/GC APTIMA®, STI Cervicitis Panel, Urine Trichomonas
Use
This is a multi-pathogen nucleic acid amplification test (NAAT) panel designed to assist clinicians in diagnosing the underlying cause of cervicitis symptoms by simultaneously detecting C. trachomatis, N. gonorrhoeae, T. vaginalis, and M. genitalium in a single urogenital specimen such as a SureSwab® sample. It enables efficient evaluation of common sexually transmitted infections in symptomatic females to guide appropriate treatment.
Special Instructions
Orderable as a combined cervicitis panel (test code 36962), this includes all four component assays but individual components (CT, NG, TV, M. genitalium) may also be ordered separately. The panel relies on a single urogenital specimen from devices like SureSwab®. Collection via Pap vial is no longer acceptable. Transcription-Mediated Amplification (TMA) is utilized as the testing methodology.
Limitations
Not all cervicitis cases are due to the four tested pathogens; other causes may not be detectable by this panel. False negatives may occur in very early or low-load infections. Specimen degradation or improper collection may affect the accuracy. This panel does not diagnose antibiotic resistance or quantify pathogen load.
Methodology
NGS
Biomarkers
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided
Collection Instructions
No Pap vial; use urogenital SureSwab® or similar urogenital swab.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Urine: 30 days |
| Refrigerated | Urine: 30 days |
| Frozen | Urine: 90 days |
Other tests from different labs that may be relevant